Discover 901 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 901
Multi-Center Clean Air Randomized Controlled Trial in COPD
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Birmingham AL, Iowa City IA, Cleveland OH, Ann Arbor MI,
Sponsor: JHSPH Center for Clinical Trials
Sex: All
Age: 40+
Code: NCT06376994
Phase 3, Recruiting
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Location: Birmingham AL, Atlanta GA, Franklin TN, Nashville TN,
Sponsor: United Therapeutics
Sex: All
Age: 18+
Code: NCT05943535
Phase 3, Recruiting
Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention
for
HIV Seropositivity
Location: Birmingham AL, Huntsville AL, Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18 - 49
Code: NCT05723653
Recruiting
A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata
for
Alopecia Areata
Location: Birmingham AL, Louisville KY, Charlotte NC,
Sponsor: AnaptysBio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05205070
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Migraine
Location: Birmingham AL, Marietta GA, Chattanooga TN, Atlanta GA,
Sponsor: TriGemX Bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07645924
Phase 3, Recruiting
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
for
Type 2 Diabetes
Location: Birmingham AL, Columbus GA, Cordele GA, Winter Park FL,
Sponsor: Biomea Fusion Inc.
Sex: All
Age: 18 - 70+
Code: NCT07502508
Phase 2, Recruiting
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Acute Migraine
Location: Birmingham AL, Marietta GA, Chattanooga TN, Atlanta GA,
Sponsor: TriGemX Bio, Inc.
Sex: All
Age: 18+
Code: NCT07674654
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Birmingham AL, Nashville TN, Edwardsville IL,
Sponsor: Dianthus Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06858579
Phase 3, Recruiting
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
for
Focal Seizure, Epilepsy, Focal Epilepsy
Location: Birmingham AL, Atlanta GA, Gulf Breeze FL, Asheville NC,
Sponsor: Rapport Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT07563881
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)
for
Alpha 1-Antitrypsin Deficiency
Location: Birmingham AL, Charleston SC, Boston MA
Sponsor: Beam Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT06389877
Phase 1, Phase 2, Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
for
Peripheral Arterial Disease
Location: Birmingham AL, Jackson TN, Jefferson City TN,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07223593
Phase 3, Recruiting
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease